These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11642504)

  • 1. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis.
    Burt RK; Barr W; Oyama Y; Traynor A; Slavin S
    J Rheumatol Suppl; 2001 Oct; 64():42-8. PubMed ID: 11642504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens.
    Oyama Y; Traynor AE; Barr W; Burt RK
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S81-3. PubMed ID: 12931250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
    Nash RA
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.
    Tapprich C; Fenk R; Schneider P; Bernhardt A; Haas R; Kobbe G
    Bone Marrow Transplant; 2003 Sep; 32(6):629-31. PubMed ID: 12953137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
    Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
    Kashyap A; Snowden J
    J Rheumatol Suppl; 2001 Oct; 64():39-41. PubMed ID: 11642503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients.
    Burt RK; Georganas C; Schroeder J; Traynor A; Stefka J; Schuening F; Graziano F; Mineishi S; Brush M; Fishman M; Welles C; Rosen S; Pope R
    Arthritis Rheum; 1999 Nov; 42(11):2281-5. PubMed ID: 10555021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
    Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
    Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
    Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A
    Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience.
    Shimoni A; Nagler A
    Curr Hematol Rep; 2004 Jul; 3(4):242-8. PubMed ID: 15217553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell transplantation for rheumatoid arthritis--Australian experience.
    Moore J; Milliken S; David ; Biggs J; Brooks P
    J Rheumatol Suppl; 2001 Oct; 64():8-12. PubMed ID: 11642509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.